Evaluation and comparison of a new DOTA and DTPA-bombesin agonist in vitro and in vivo in low and high GRPR expressing prostate and breast tumor models
| Cobertura |
I |
|---|---|
| Data(s) |
2015
06/01/2015
06/01/2015
|
| Formato |
91-101 |
| Identificador |
0969-8043 http://hdl.handle.net/123456789/23226 v. 96 |
| Relação |
Applied Radiation and Isotopes |
| Direitos |
openAccess |
| Palavras-Chave | #RADIOPHARMACEUTICALS #DTPA #LEBELLED COMPOUNDS #INDIUM 111 #NEOPLASMS #PEPITIDES #IMPURITIES #COMPARATIVE EVALUATIONS |
| Tipo |
Artigo de periódico |
